Second, we need new kinds of partnerships between academia and government and the private sector and patient organizations, just like the one I've been describing here, in terms of the way in which we could go after repurposing new compounds.
２つ目に 学術界と政府と民間企業 そして患者協会との間で 新たな協力関係が必要です 私がご説明してきたような 新たな化合物の再利用を促すような関係です